Trials / Unknown
UnknownNCT03803930
Comparing of a 22G EUS Procore Fine Needle Biopsy Device and a 20G EUS Procore Fine Needle Biopsy Device
Comparing of a 22G EUS Procore Fine Needle Biopsy Device and a 20G EUS Procore Fine Needle Biopsy Device for Solid Pancreatic Lesions: a Prospective Multi-center, Randomized, and Controlled Trial
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1,224 (estimated)
- Sponsor
- Huazhong University of Science and Technology · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare the diagnosis accuracy of 22G EUS Procore fine needle biopsy (FNB)device and 20G EUS Procore fine needle biopsy device for solid pancreatic lesions.
Detailed description
This is a single-blind, randomized, controlled trial. One thousand two hundred and twenty four patients with solid pancreatic lesions referred for EUS guided fine needle biopsy will be randomly assigned to 4 arms. For arm A1 which will be used with 22G EUS Procore fine needle biopsy device, the pass sequence is slow pull(SP)-modified wet suction technique(MWST)-slow pull(SP)-modified wet suction technique(MWST). For arm A2 with 22G EUS Procore fine needle biopsy device, the pass sequence is MWST-SP-MWST-SP. For arm B1 with 20G EUS Procore fine needle biopsy device, the pass sequence is SP-MWST-SP-MWST. For arm B2 with 20G EUS Procore fine needle biopsy device, the pass sequence is MWST-SP-MWST-SP. All procedures will be performed by experienced echoendoscopists, and the patients and assessors (cytologists and pathologists) will be blinded during the entire study. The primary outcome measure is the diagnosis yield. Secondary outcome measures are specimen quality.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Using 22G FNB, the first pass is SP | Using 22G FNB, the first pass is SP and the pass sequence is SP-MWST-SP-MWST. |
| DEVICE | Using 22G FNB, the first pass is MWST | Using 22G FNB, the first pass is MWST and the pass sequence is MWST-SP-MWST-SP. |
| DEVICE | Using 20G FNB, the first pass is SP | Using 20G FNB, the first pass is SP and the pass sequence is SP-MWST-SP-MWST. |
| DEVICE | Using 20G FNB, the first pass is MWST | Using 20G FNB, the first pass is MWST and the pass sequence is MWST-SP-MWST-SP.technique-slow pull. |
Timeline
- Start date
- 2019-03-01
- Primary completion
- 2020-06-01
- Completion
- 2020-08-01
- First posted
- 2019-01-15
- Last updated
- 2019-01-17
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03803930. Inclusion in this directory is not an endorsement.